Trial intelligence / Profile preview

Preoperative liraglutide before Roux-en-Y gastric bypass in type 2 diabetes mellitus

2011-003614-17Phase 4Terminated

Sponsor
University Medical Center Hamburg-Eppendorf
Start
Nov 2011
Modality
Peptides
Countries
1
01

Overview

Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) and obesity comparing Liraglutide pretreatment with Placebo pretreatment (2 arms). Primary endpoint: Preoperative body weight. Started Nov 2011; status: terminated.

02

Drugs

03

Conditions

type 2 diabetes mellitus (T2DM)obesity

Beyond the preview

Go deeper on 2011-003614-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-003614-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call